HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Mutations of ACVRL1 gene in a pedigree with hereditary hemorrhagic telangiectasia].

AbstractOBJECTIVE:
To identify the activin A receptor type II-like 1 gene (ACVRL1) mutations in a Chinese family with hereditary hemorrhagic telangiectasia (HHT2).
METHODS:
The exons 3, 7 and 8 of ACVRL1 gene of the proband and her five family members were amplified by polymerase chain reaction (PCR), and the PCR products were sequenced.
RESULTS:
The proband had obvious telangiectasis of gastric mucosa, and small arteriovenous fistula in the right kidney. All the patients in the HHT2 family had iterative epistaxis or bleeding in other sites, and had telangiectasis of nasal mucosa, tunica mucosa oris and finger tips. ACVRL1 gene analysis confirmed that there is frameshift mutation caused by deletion of G145 in exon 3 in the 4 patients, but the mutation is absent in 2 members without HHT2.
CONCLUSION:
The HHT2 family is caused by a 145delG mutation of ACVRL1 gene, resulting in frameshift and a new stop codon at codon 53.
AuthorsJie-wei Luo, Hui Chen, Liu-qing Yang, Ai-lan Zhu, Yan-an Wu, Jian-wei Li
JournalZhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics (Zhonghua Yi Xue Yi Chuan Xue Za Zhi) Vol. 25 Issue 3 Pg. 308-10 (Jun 2008) ISSN: 1003-9406 [Print] China
PMID18543223 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ACVRL1 protein, human
  • Activin Receptors, Type II
Topics
  • Activin Receptors, Type II (genetics)
  • Exons (genetics)
  • Female
  • Frameshift Mutation (genetics)
  • Humans
  • Male
  • Mutation
  • Polymerase Chain Reaction
  • Telangiectasia, Hereditary Hemorrhagic (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: